Single-cell-derived ferroptosis signature predicts prognosis and therapy response in esophageal squamous cell carcinoma - Top-Institutions - MDSpire

Single-cell-derived ferroptosis signature predicts prognosis and therapy response in esophageal squamous cell carcinoma

  • By

  • Qin Xu

  • Yu Ma

  • Xuanqi Huang

  • Elyar abdukirim

  • Meng Yang

  • Chunli Song

  • Meng Liu

  • July 17, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    State University of Campinas
    State University of Campinas

    São Paulo, Brazil

    Key Differentiators

    • Oncology

  • #4

    Federal Technological University of Paraná
    Federal Technological University of Paraná

    Londrina, Brazil

    Key Differentiators

    • Oncology

  • #5

    The Cancer Genome Atlas (TCGA)
    The Cancer Genome Atlas (TCGA)

    N/A, N/A

    Key Differentiators

    • Oncology

Original Source(s)

Single-cell-derived ferroptosis signature predicts prognosis and therapy response in esophageal squamous cell carcinoma

  • by Qin Xu, Yu Ma, Xuanqi Huang, Elyar abdukirim, Meng Yang, Chunli Song, Meng Liu

  • July 17, 2026

Related Content

Distribution analysis of gynecological carcinomas with concurrent second primary carcinomas

Outcomes of malignant orbital tumors: a 22-year Norwegian single-center series

Clinical features and treatment challenges of HER2-positive primary breast squamous cell carcinoma: a case report and literature review